Interviews

Dr Leora Horn on How Biosimilar Pegfilgrastim Could Improve Patient Access
October 16, 2017 – 
Cost will be one of the most important factors to determine whether or not a biosimilar pegfilgrastim improves patient access to the treatment, said Leora Horn, MD, clinical director of thoracic oncology at Vanderbilt-Ingraham Cancer Center, assistant vice chancellor for faculty development at Vanderbilt University Medical Center.
Kim Woofter on How Data Will Change Care Delivery in the Next 5 Years
October 15, 2017 – 
Value-based care will start to transition from being an option to being a requirement, and better data will be needed to improve how care is delivered to patients, said Kim Woofter, executive vice president of strategic alliances and practice innovation at the Advanced Centers for Cancer Care.
Dr John Eikelboom Compares the COMPASS Trial to EUCLID and PEGASUS
October 14, 2017 – 
Compared with the trial results of EUCLID and PEGASUS, the COMPASS trial advances the field of cardiovascular disease in combination therapies, said John Eikelboom, MD, of McMaster University.
Linda Schwimmer: New Scorecard Will Give a Better Sense of Whether APMs Are Working
October 13, 2017 – 
As the healthcare industry tries to move away from fee-for-service, the new Scorecard being developed by Catalyst for Payment Reform will help states get a better understanding of whether or not new payment models are actually working, explained Linda Schwimmer, CEO and president of the New Jersey Health Care Quality Institute.
Dr Charlie Fazio on the Uncertainty of Transitioning to Value-Based Care
October 13, 2017 – 
Charlie Fazio, MD, senior vice president and medical director of HealthPartners discusses the uncertainty felt by practices as the industry moves from fee-for-service to value-based care.
Dr Naiyer A. Rizvi on PD-1 Antibodies in Lung Cancer
October 11, 2017 – 
Naiyer A. Rizvi, MD, director of thoracic oncology and immunotherapeutics at Columbia University Medical Center discusses the effectiveness of PD-1 antibodies in lung cancer.
Teri Kovach on Challenges of Implementing a New EHR
October 10, 2017 – 
Getting people on board when a new electronic health record (EHR) is being implemented is one of the biggest obstacles to overcome and is important for the success of the new EHR, said Teri Kovach, RN, OCN, compliance officer and charge nurse at Salish Cancer Center.
Dr Michael Kolodziej on How Technology Will Improve Patient Access to Clinical Trials
October 09, 2017 – 
Technological advances will lead to improvements in clinical trials and greater participation in trials by patients, explained Michael Kolodziej, MD, national medical director of managed care strategy at Flatiron Health.
Dr Peter Aran: Smaller Practices Need Help Transitioning to Value-Based Payments
October 08, 2017 – 
Payers and other organizations can help smaller practices develop the necessary infrastructure to complete their healthcare transformation, said Peter Aran, MD, medical director of population health management at Blue Cross Blue Shield of Oklahoma.
Tesh Khullar: Community Oncologists Have to Be Business Experts to Stay Alive
October 06, 2017 – 
As the health system evolves it will become increasingly important that practices understand business, explained Tesh Khullar, senior vice president of provider solutions at Flatiron Health.
Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome to the new and improved AJMC.com, the premier managed markets network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!